✦ LIBER ✦

Synergistic activity of letrozole and sorafenib on breast cancer cells

✍ Scribed by Mara A. Bonelli; Claudia Fumarola; Roberta R. Alfieri; Silvia La Monica; Andrea Cavazzoni; Maricla Galetti; Rita Gatti; Silvana Belletti; Adrian L. Harris; Stephen B. Fox; Dean B. Evans; Mitch Dowsett; Lesley-Ann Martin; Alberto Bottini; Daniele Generali; Pier Giorgio Petronini

Book ID: 106378565
Publisher: Springer US
Year: 2010
Tongue: English
Weight: 551 KB
Volume: 124
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-009-0714-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zoledronic acid (ZOL) and letrozole (LET

Zoledronic acid (ZOL) and letrozole (LET) induce synergistic levels of apoptosis in breast cancer cells

✍ H.L. Neville-Webbe; D. Lefley; R.E. Coleman; I. Holen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Synergistic anti-cancer activity of the

Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells

✍ Wu, Guo-Sheng; Lu, Jin-Jian; Guo, Jia-Jie; Huang, Ming-Qing; Gan, Li; Chen, Xiu- 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 867 KB

Combining Nanoliposomal Ceramide with So

Combining Nanoliposomal Ceramide with Sorafenib Synergistically Inhibits Melanoma and Breast Cancer Cell Survival to Decrease Tumor Development

✍ Tran, M. A.; Smith, C. D.; Kester, M.; Robertson, G. P. 📂 Article 📅 2008 🏛 American Association for Cancer Research 🌐 English ⚖ 639 KB

Combined effects of the bisphosphonate,

Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction

✍ Neville-Webbe, H L; Coleman, R E; Holen, I 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 530 KB

Synergistic repression of estrogen recep

Synergistic repression of estrogen receptor transcriptional activity by FHL2 and Smad4 in breast cancer cells

✍ Zhihong Xiong; Lihua Ding; Junzhong Sun; Jia Cao; Jing Lin; Zhaohui Lu; Yufei Li 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 390 KB

## Abstract Four and a half LIM domain protein 2 (FHL2) has been implicated in development and progression of various types of cancers. However, little is known about the biological function of FHL2 in breast cancer. Here, we report that FHL2 physically and functionally interacts with estrogen rece

Synergistic Effects Induced by Cycloprod

Synergistic Effects Induced by Cycloprodigiosin Hydrochloride and Epirubicin on Human Breast Cancer Cells

✍ Daigo Yamamoto; Kanji Tanaka; Koji Nakai; Tetsuya Baden; Kentaro Inoue; Chizuko 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 146 KB